Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Can Data Management Tools Improve Research Efficiency and Reproducibility?
Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
How Can Phones and Drones Help Stop a Cancer Causing Parasite?
Urogenital schistosomiasis affects over 200 million people globally, causing cancer, infertility, and chronic...